sarepta therapeutics inc
(AB3A:German Stock Exchange)
Edward M. Kaye M.D., Ph.D.
Chief Medical Officer and Senior Vice President, Sarepta Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 7 board members in 1 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. Edward M. Kaye, also known as Ed, M.D. Ph.D. has been the Chief Medical Officer and Senior Vice President of AVI BioPharma Inc. since June 20, 2011. Dr. Kaye serves as a Neurological Consultant at Children's Hospital of Boston. He has specific experience with pediatric neuromuscular conditions. Dr. Kaye joined AVI from Genzyme, where he served as Group Vice President for Clinical Development and Therapeutic Head for Lysosomal Storage Disorders and Neurodegenerative ...
215 First StreetPhone: 857-242-3700
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
Stritch School Of Medicine, Loyola University
Loyola University of Chicago
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|William A. Carter M.D.||Chairman, Chief Executive Officer, President, Chief Scientific Officer, Chairman of Executive Committee, Member of Strategic Planning Committee and Member of Disclosure Controls Committee|
Hemispherx Biopharma, Inc.
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Friedhelm Blobel Ph.D.||Chief Executive Officer, President, Executive Director and Member of Business Development Committee|
SciClone Pharmaceuticals, Inc.
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|3.0M GBP||Compensation as of Fiscal Year 2013.|